Literature DB >> 16797773

Intrahepatic gene expression in human alcoholic hepatitis.

Devanshi Seth1, Mark D Gorrell, Shaun Cordoba, Geoffrey W McCaughan, Paul S Haber.   

Abstract

BACKGROUND/AIMS: Alcoholic hepatitis remains an important cause of morbidity and mortality. Treatment remains unsatisfactory, in part, due to limited understanding of the pathogenesis. The aim of this study is to define the global intrahepatic expression profile of human alcoholic hepatitis.
METHODS: Gene expression was analysed by DNA microarray on RNA isolated from liver of patients with alcoholic hepatitis (AH, n = 8), alcoholic steatosis (AS, n = 9) and explants from non-diseased donor liver controls (ND, n = 7). Differential expression of selected genes was confirmed by real-time RT-PCR and immunohistochemistry.
RESULTS: Cluster analysis allowed differentiation of alcoholic hepatitis from alcoholic steatosis. The gene expression profile of AH revealed 586 genes differentially expressed from AS and 211 genes differentially expressed from that of ND liver. In comparison, only 98 genes were differentially expressed in AS from ND. Novel differentially expressed genes in AH in comparison to ND and AS included claudins, osteopontin, CD209, selenoprotein and genes related to bile duct proliferation. Real-time RT-PCR confirmed up-regulation of IL-8, osteopontin, and TNFRSF14 and down-regulation of SAMeS and CD209.
CONCLUSIONS: This study has defined the intrahepatic gene expression profile of human alcoholic hepatitis and revealed a number of novel differentially expressed genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16797773     DOI: 10.1016/j.jhep.2006.04.013

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  31 in total

Review 1.  A Unifying Hypothesis Linking Hepatic Adaptations for Ethanol Metabolism to the Proinflammatory and Profibrotic Events of Alcoholic Liver Disease.

Authors:  Zhi Zhong; John J Lemasters
Journal:  Alcohol Clin Exp Res       Date:  2018-09-17       Impact factor: 3.455

2.  Second hits exacerbate alcohol-related organ damage: an update.

Authors:  Natalia A Osna; Murali Ganesan; Devanshi Seth; Todd A Wyatt; Srivatsan Kidambi; Kusum K Kharbanda
Journal:  Alcohol Alcohol       Date:  2021-01-04       Impact factor: 2.826

Review 3.  Alcoholic liver disease: pathogenesis and new therapeutic targets.

Authors:  Bin Gao; Ramon Bataller
Journal:  Gastroenterology       Date:  2011-09-12       Impact factor: 22.682

4.  Discoidin domain receptor 1: isoform expression and potential functions in cirrhotic human liver.

Authors:  Sunmi Song; Nicholas A Shackel; Xin M Wang; Katerina Ajami; Geoffrey W McCaughan; Mark D Gorrell
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

5.  Pattern analysis uncovers a chronic ethanol-induced disruption of the switch-like dynamics of C/EBP-β and C/EBP-α genome-wide binding during liver regeneration.

Authors:  Lakshmi Kuttippurathu; Biswanath Patra; Daniel Cook; Jan B Hoek; Rajanikanth Vadigepalli
Journal:  Physiol Genomics       Date:  2016-11-04       Impact factor: 3.107

Review 6.  Alcoholic liver disease: treatment.

Authors:  Ki Tae Suk; Moon Young Kim; Soon Koo Baik
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

7.  Osteopontin is an important mediator of alcoholic liver disease via hepatic stellate cell activation.

Authors:  Devanshi Seth; Alastair Duly; Paul C Kuo; Geoffrey W McCaughan; Paul S Haber
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 8.  New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases.

Authors:  Jessica A Williams; Sharon Manley; Wen-Xing Ding
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 9.  Pathogenesis and Management of Alcoholic Liver Disease.

Authors:  M Omar Farooq; Ramon Bataller
Journal:  Dig Dis       Date:  2016-05-11       Impact factor: 2.404

10.  Osteopontin Expression in Patients with Hepatolith.

Authors:  Bum Soo Kim; Sun Hyung Joo; Sung Jig Lim; Kwang Ro Joo
Journal:  Indian J Surg       Date:  2013-05-18       Impact factor: 0.656

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.